New target agents in the treatment of colorectal cancer patients

Author： Tonini Giuseppe Schiavon Gaia Vincenzi Bruno Santini Daniele

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.2, Iss.6, 2007-06, pp. : 861-871

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Agents for Colorectal Cancer

By Mulcahy Mary F. Benson Al B.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 1, 2003-03 ,pp. : 125-136

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

The new paradigm in the treatment of colorectal cancer: are we hitting the right target?

By Baranda Joaquina Williamson Stephen

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 3, 2007-03 ,pp. : 311-324

Informa Healthcare

Access to resources Recommend Favorite

Protein kinase G as a therapeutic target for the treatment of metastatic colorectal cancer

By Browning Darren D

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 3, 2008-03 ,pp. : 367-376

Informa Healthcare

Access to resources Recommend Favorite

Colorectal Cancer Chemotherapy: The Evolution of Treatment and New Approaches

Current Medicinal Chemistry, Vol. 24, Iss. 15, 2017-06 ,pp. : 1537-1557

Bentham Science Publishers

Access to resources Recommend Favorite

Capecitabine is `a new effective oral treatment option' for patients with advanced and/or metastatic colorectal cancer

Inpharma, Vol. 1, Iss. 1234, 2000-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite